Condition
Newly Diagnosed Glioblastoma clinical trials and research
As of November 12, 2026, Find a Trial lists 8 Newly Diagnosed Glioblastoma clinical trials that are recruiting, at sites in 5 countries (most in United States (6), Australia (1), Germany (1)). By phase: Phase 2 (2), Phase 1/2 (2), Phase 1 (1), Early Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 8Clinical trials
- 5Countries
Newest Newly Diagnosed Glioblastoma clinical trials
All recruiting trials (8)
-
Maintenance radiotherapy after standard glioblastoma treatment
This study tests whether a single 2 Gy maintenance radiotherapy dose after standard treatment is safe and feasible for adults with newly diagnosed glioblastoma.
-
AAV dual-payload gene therapy injected directly into high-grade glioma to kill tumor cells and stimulate immune attack.
This will try TGX-007, a virus-delivered gene therapy given into the tumor together with oral valaciclovir, in adults 18–70 with newly diagnosed or recurrent glioblastoma to see if it safely kills tumor cells and boosts immune response.
-
Silevertinib plus temozolomide for newly diagnosed GBM with unmethylated MGMT and EGFRvIII
This trial tests whether adding silevertinib to standard temozolomide helps people with newly diagnosed glioblastoma that have EGFRvIII and an unmethylated MGMT promoter live longer without the cancer getting worse.
-
Anterior (front) temporal lobe removal for temporal glioblastoma
This will see if removing the front part of the temporal lobe (anterior temporal lobectomy) helps people with newly diagnosed temporal-lobe glioblastoma live longer than standard complete tumor removal (gross-total resection).
-
Nivolumab with or without relatlimab for newly diagnosed IDH‑wildtype glioblastoma
This trial will test whether giving nivolumab alone or together with relatlimab around surgery helps adults with newly diagnosed IDH‑wildtype glioblastoma.
-
New cancer vaccine for glioblastoma patients
This study is testing a new cancer vaccine for people with newly diagnosed glioblastoma to see if it can help boost their immune response after standard treatment.
-
Personalized drug screening for glioblastoma treatment
This study is testing if personalized combinations of FDA-approved drugs can improve treatment for people with newly diagnosed glioblastoma when used with standard therapy.
-
BRiTE: a brain-penetrant bispecific T cell engager for EGFRvIII-positive glioblastoma
This Phase 1 study tests the safety of BRiTE, a brain-delivered bispecific T cell engager, in adults with newly diagnosed or recurrent EGFRvIII-positive glioblastoma.
Related topics
Quick answers
How many Newly Diagnosed Glioblastoma clinical trials are recruiting right now?
8, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 5 countries. The most sites are in United States (6 trials), Australia (1 trial), Germany (1 trial), United Kingdom (1 trial), France (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 2, Phase 1/2: 2, Phase 1: 1, Early Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.